Facebook
Twitter
LinkedIn
Forward- KELLY KALSCHEUR
Series Overview
This weekly conference focuses on the care of pediatric cardiac patients through case-based discussion, contect-expert presentations, and journal reviews. Learning occurs with the interprofessional team to incorporate best approaches into the practice of the entire care team.
Target Audience
Pediatric cardiologists, cardiothoracic surgeons, pediatric critical care physicians (MD, DO), cardiac nurses (RN, APRN), PAs, and students.
Planning Committee
| Luke Lamers, MD, Chair | Kelly Kalscheur, Coordinator | Jenna Torgeson, APNP |
Accreditation
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate per session to meet the needs of advanced practice nurses.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational series, participants will:
- Be better prepared to use current guidlines, recent evidence and best practice related to diagnoses and treatment of congenital and acquired cardiac disease.
- Increase appropriate application of echocardiogram as a diagnostic and treatment techniques of pediatric heart disease.
- Address lab operations concerns raised during quality study analysis of lab function and develop a plan with the echo lab team to address discrepancies.
- Engage in team-based management of the appropriate application of new diagnostic and treatment techniques to improve pediatric cardiology care.
